J Neuroimmunol 2001 Jan 11;120(1-2):138-45
Weinshenker BG, Hebrink D, Kantarci OH, Schaefer-Klein J, Atkinson E, Schaid D, McMurray CM.
Department of Neurology, Mayo Clinic and Mayo Foundation, 200 First Street SW, 55905, Rochester, MN, USA
Transforming growth factor beta1 (TGFbeta1) is a Th2 cytokine encoded on chromosome 19q13, a region possibly linked to multiple sclerosis (MS).
TGFbeta1 exerts favorable effects on experimental allergic encephalomyelitis.
We performed a comprehensive search for genetic variants in this gene in 122 population-based sporadic cases of MS.
We detected six variants, including three missense variants.
We tested for association of the variants with susceptibility and course of MS and for linkage and transmission disequilibrium in a family series consisting of 395 samples in 59 pedigrees.
Genetic variation in TGFB1 does not
appear to contribute in a major way to susceptibility to MS.
PMID: 11694328 [PubMed - in process]